SCIENTIFIC PROGRAMME

DRAFT PROGRAMME

7 December 2018, Friday 
PRE-CONFERENCE WORKSHOP

08:00 – 09:30

Nutrional Support in Gastrointestinal Cancer Patients
Workshop for GI Oncologists
Course chairs:
Seref Komurcu(Turkey), Orhan Turken(Turkey)

  • Assesment of nutritional status in cancer patients
    – Saadettin Kilickap(Turkey)
  • Nutritional Counselling in GI Cancer patients: ESPEN guidelines
    Meltem Halil(Turkey)
  • Complementary nutrients and oral nutritional supplements
    – Timucin Cil(Turkey)
  • Parenteral nutrition in cancer patients
    – Osman Abbasoglu(Turkey)
  • Pharmacological and Multimodality Therapy for Cancer Cachexia
    Tugba Yavuzsen(Turkey)
09:30 – 10:10

Session I: Opening session
Chairs
: Suayib Yalcin(Turkey), Faruk Aykan(Turkey), Philip Agop Philip(USA)

09:30-09:50

  • Opening Lecture: Increasing role of precision medicine in the treatment of gastrointestinal cancer
    Axel Grothey(USA)

09:50 -10:10

  • Biomarkers for immunotherapy in Gastrointestinal Cancers
    – Aung Naing(USA)
10:10 – 10:55

Session II: Esophageal Cancer Management How Should I Treat in 2018
Chairs:
Bulent Tirnaksiz(Turkey), Durmus Etiz(Turkey)

10:10-10:35

  • Esophageal Cancer Management how should I treat in 2018
     Jamal Khader(Jordan)

10:35-10:55

  • Case discussion
    Umut Kefeli(Turkey)
10:55 – 11:15 Coffee Break
11:15 – 12:25

Session III: Key Selected Abstracts (Hall B)
Chairs:
Berna Oksuzoglu(Turkey), Isil Somali(Turkey), Hakan Harputluoglu,(Turkey)

– OP-002 Murat Sari

– OP-003 Irem Bilgetekin

– OP-004 Derya Kıvrak Salim

– OP-005 – Cengiz Yilmaz

– OP-006 – Huseyin Engin

– OP-007 – Mehmet Ali Nahit Sendur

– OP-008 – Mahmut Onur Kulturoglu

– OP-009 – Havva Yesil Cinkir

– OP-010 – Osman Kostek

– OP-011 – Tarık Demir

– OP-012 – Mehmet Kursad Turkdogan

– OP-013 – Ozturk Ates

– OP-014 – Huseyin Onur Aydin

11:15 – 12:00

Bayer Satellite Symposium
Stivarga Across Different Indications
Speakers:
Serdar Turhal(Turkey), Suayib Yalcin(Turkey)

12:00 – 12:30 Lunch Symposium: Getting help from the pathologist (PDL1 MSI and molecular classification of gastric cancer)
Chairs:
Coskun Tecimer(Turkey), Abdurrahman Isikdogan(Turkey), Murat Gurkaynak(Turkey)
Pathology: Sibel Erdamar(Turkey)
Discussants: Yesim Yildirim(Turkey),Yusuf Karakus(Turkey), Ebru Cilbir(Turkey)
12:30 – 12:50 Theronostic Oncology
Chairs: Omer Ugur(Turkey), Necdet Uskent(Turkey)
Speaker: Meltem Caglar Tuncali(Turkey)
12:50 – 13:30 LUNCH
13:30 – 14:10 Session IV: Challenge the Experts
Chairs: Ibrahim Petekkaya(Turkey), Pervin Hurmuz(Turkey), Tarkan Yetisyigit(Turkey)
Experts: Axel Grothey(USA), Aung Naing(USA), Demetris Papamichael(Cyprus), Philip Agop Philip(USA)
Challengers: Sahin Lacin(Turkey), Utku Burak Bozbulut(Turkey), Ozcan Yildiz(Turkey)
14:10 – 14:30

Session IV: Increasing role of immunotherapy in Oncology

  • Immunotherapy yesterday, today and tomorrow
    – Berna Bozkurt(Turkey)
14:30 – 15:30

Session V: Gastric Cancer: Towards more Individualized Approach
Chairs:
Fuat Demirelli(Turkey), Salim Basol Tekin(Turkey), Demetris Papamichael(Cyprus)

14:30-14:50

  • Adjuvant/neoadjuvant therapy in gastric cancer
    – Mehmet Akif Ozturk(Turkey)

14:50-15:10

  • Getting lessons from the negative trials: Why did they fail
    – Nuri Karadurmus(Turkey)

15:10-15:30

  • Advances in the systemic treatment of advanced gastric cancer
    Ofer Purim(Israel)
    Discussants: Gokhan Celenk(Turkey), Ozturk Ates(Turkey), Gokhan Ucar(Turkey), Ismail Ozer(Turkey)
15:30 – 16:25

Session VI: Key Selected Abstracts (Hall B)
Chairs:
Mehmet Artac(Turkey), Metin Seker(Turkey), Pervin Hurmuz(Turkey)

– OP-015 – Abdullah Sakin

– OP-016 – Deniz Atasoy

– OP-017 – Metin Demir

– OP-018 – Fatma Kulali

– OP-019 Aytul Ozgen

– OP-020 – Semih Hot

– OP-021 – Aytul Ozgen

– OP-022 – Canan Karan

– OP-023 – Selim Yalcin

– OP-024 – Dilek Erdem

– OP-025 – Yonca Yilmaz Urun

15:30 – 15:50 Coffee Break
15:50 – 16:40

Selected Abstracts 

Chairs: Huseyin Engin(Turkey), Omer Dizdar(Turkey), Saadettin Kilickap(Turkey)

– OP-026 – Huseyin Abali

– OP-027 – Yusuf Karakas

– OP-028 – Gokhan Ucar

– OP-029 – Sahin Lacin

– OP-030 – Halil Cumhur Yildirim

– OP-031 – Duygu Cevik

– OP-032 – Gokhan Kocaman

– OP-034 – Esra Arslan

– OP-035 – Emrah Arslan

16:40 – 17:40

Session VII: Hepatocellular Tumors
Chairs:
Haluk Onat(Turkey), Feyyaz Ozdemir(Turkey)

16:40-17:00

  • Locoregional treatment: Choosing right modality for the right patient
    – Bora Peynircioglu(Turkey)

17:00-17:20

  • Advances in the systemic treatment of Hepatocellular cancer
    – Suayib Yalcin(Turkey)

17:20-17:40

  • Learning from the pediatric oncologist: Similarities and peculiarities of hepatocellular cancer in pediatric patients
    Tezer Kutluk(Turkey)

Discussants: Metin Demir(Turkey), Selim Yalcin(Turkey), Canan Karan(Turkey), Havva Yesil Cinkir(Turkey)

17:40 – 18:20

Session VIII: Multidisciplinary Approach to Biliary Tract Cancer
Chairs: Evin Buyukunal(Turkey), Arzu Yaren(Turkey), Ilias Athanasiadis(Greece)

17:40-18:00

  • Systemic treatment
    TBA

18:00-18:20

  • Cholangiocarcinoma anf Gallbladder cancer, multimodality imaging approach
    Ruzica Maksimovic(Serbia)

Discussants: Devrim Akinci(Turkey) Cenk Sokmensuer(Turkey)

 

8 December 2018, Saturday  

08:00 – 08:30

Session IX: Anal Cancer
Chairs:
Mahmut İlhan(Turkey), Fatih Kose(Turkey)

  • Advances is the systemic treatment for metastatic disease
    – Mehmet Artac(Turkey)
  • Multimodality treatment for localized disease
    Ferah Yildiz(Turkey)
08:30 – 09:00

Session X: Management of NETs
Chairs:
Ilhan Oztop(Turkey), Senem Karabulut(Turkey), Aziz Karaoglu(Turkey)

  • Optimal sequencing of treatment in advanced GEPNETS
    Ozcan Yildiz(Turkey)
09:00 – 10:20

Session XI: Optimizing Outcomes in Colorectal Cancer
Chairs:
Bülent Karabulut(Turkey), Berksoy Sahin(Turkey), Ioannis Boukovinas(Greece)

09:00-09:20

  • Update on adjuvant therapy in colon cancer
    – Ilias Athanasiadis(Greece)

09:20-09:40

  • Sequencing of systemic treatment in mCRC: According to the international guidelines
    – Marc Peeters(Belgium)

09:40-10:00

  • Role of maintenance therapy in advanced CRC?
    Cigdem Afsar(Turkey)

10:00-10:20

  • Treatment beyond second line: Choosing patients
    – Dilek Erdem(Turkey)

Discussants: Vildan Kayku(Turkey)Utku Burak Bozbulut(Turkey), Yusuf Karakas(Turkey)

10:20 – 10:40 Coffee Break
10:40 – 11:45

Session XII: Localized Rectal Cancer
Chairs:
Faruk Zorlu(Turkey), Oktar Asoğlu(Turkey), Marina Nikitovic(Serbia)

10:40-10:55

  • Individualizing adjuvant/ neoadjuvant treatment for rectal cancer
    – Ugur Selek(Turkey)

10:55-11:10

  • Surgical management of rectal cancer: Where do we stand today
    – Ethem Gecim(Turkey)

11:10-11:30

  • Assessment of rectal cancer response to neoadjuvant chemoradiation and its impact to clinical decision making
    Ivana Blazic (Serbia)

11:30-11:45

  •  Adjuvant treatment for rectal cancer
    Leyla Ozer(Turkey)

Discussants: Fatma Kulali(Turkey), Esra Arslan(Turkey), Mahmut Onur Kulturoglu(Turkey), Nilay Sengul Samanci(Turkey)

11:45 – 12:30
Amgen Satellite Symposium
What is the optimal treatment sequence in RAS-WT mCRC?
Chair: Feyyaz Özdemir(Turkey)
Speaker: 
Meinolf Karthaus (Germany)
12:30 – 13:00

Session XIII: Advanced Colorectal Cancer: Individualization of Treatment I
Chairs:
Birol Bostancı(Turkey)Ahmet Ozet(Turkey), Aung Naing(USA)

12:20-12:40

  • Molecular classification of colon cancer: Is it ready for clinical practice?
    Omer Dizdar(Turkey)

12:40-13:00

  • İmmunoterapies in mCRC: Where do we stand?
    Demetris Papamichael(Cyprus)
13:00 – 13:30 LUNCH
13:30 – 14:15 Merck Satellite Symposium
Explaining the Unexplainable: Personalized therapy for mCRC
Moderator:
Suayib Yalcin(Turkey)
Speaker:
Dan Aderka(Israel)
14:15 – 15:20

Session XIV: Pancreatic Cancer
Chairs: Fazil Aydin(Turkey), Ilhan Oztop(Turkey), Aziz Karaoglu(Turkey)

14:15-14:30

  • Adjuvant treatment in resectable pancreas cancer?
     – Sernaz Uzunoglu(Turkey)

14:30- 14:45

  • SBRT in pancreatic cancer
    Hale Basak Caglar Ozkok(Turkey)

14:45-15:00

  • Increasing role of genetics in the management of pancreatic cancer
    – Mehmet Ali Nahit Sendur(Turkey)

15:00-15:20

  • Advances in the systemic treatment of pancreatic cancer
    – Philip Agop Philip(USA)

Discussants:  Saadet Tokluoglu(Turkey), Mukremin Uysal(Turkey), Cengiz Yilmaz(Turkey), Derya Kivrak Salim(Turkey), Utku Burak Bozbulut(Turkey)Abdullah Sakin(Turkey)

15:20 – 16:05

Session XV: Update On Rare Tumors
Chairs: Murat Dincer(Turkey), Necati Alkis(Turkey)

15:20-15:40

  • Update on GIST management
    – Ioannis Boukovinas(Greece)

15:40-16:05  

  • Systemic Treatment for small intestinal adenocarcinomas
    Yesim Yildirim(Turkey)
16:05 – 16:25 Break and poster viewing
16:25 – 16:45
  • Treating gastroesophageal cancers according to molecular profiling
    – Ofer Purim(Israel)
16:45– 18:05

Session XVI: Advanced Colorectal Cancer: Individualization of Treatment III
Chairs:
Mustafa Ozdogan(Turkey), Deniz Yamac(Turkey), Dan Aderka(Israel)

16:45-17:05

  • Role of Interventional radiologists in CRC liver metastasis 
    Okan Akhan(Turkey)

17:05-17:20

  • ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer
    – Ebru Cilbir(Turkey)

17:20-17:35

  • RET alterations in mCRC
    Bulent Orhan(Turkey)

17:35-17:50

  • HER-2 positive metastatic colon cancer
    Cagatay Arslan(Turkey)

17:50-18:05

  • Targeting Wnt signaling in colorectal cancer
    Ozge Keskin(Turkey)

Discussant: Aytul Ozgen(Turkey)

18:30– 19:30

Meet the expert meeting

What is our daily practice for RAS WT 1st line mCRC Treatment?
Chair:
Suayib Yalcin (Turkey)

Speaker: Meinolf Karthaus (Germany)
Discussant: Ozcan Yildiz (Turkey)

 

9 December, 2018, Sunday  

08:30 – 09:15

Session XVII: Interactive Case Discussions
Chairs:
Ozlem Ata(Turkey), Cengiz Gemici(Turkey)

08:30 – 08:45   

  • Cholangioselluler Cancer
    Hilmi Ege(Turkey)

08:45 – 09:00     

  • Gastric cancer
    Huseyin Engin(Turkey)

09:00 – 09:15    

  • Pancreatic cancer
    Burcak Erkol(Turkey)
09:15 – 09:35

Session XVIII: Supportive Care in GI Cancers
Chairs:
Seref Komurcu(Turkey), Bulent Orhan(Turkey)

  • Principles of intensive care in gastrointestinal oncology
    – Kaya Yorganci(Turkey)
09:35 – 10:10

Session XIX: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer: Is cytoreductive surgery enough
Chairs: Erdem Goker(Turkey), Ertugrul Seyrek(Turkey), Koray Topgul(Turkey)

  • We need HIPEC
    – Selman Sokmen(Turkey)
  • Cytoreductive surgery is Enough
    – Selcuk Seber(Turkey)
10:10 – 10:30 Break and poster viewing
10:30 – 11:50

Session XX: How Can We Better Understand And Treat Metastatic Colorectal Cancer
Chairs: Hakan Akbulut(Turkey), Mehmet Alakavuklar(Turkey)

  • Understanding tumour biology and tumor resistance in metastatic colorectal Cancer
    Dan Aderka(Israel)
  • Right versus left colon: is it all?
    Meinolf Karthaus (Germany)
  • BRAF mutant Mcrc
    Hande Turna(Turkey)
  • Optimal systemic treatment strategy for advanced RAS mutant colorectal cancer
    Ali Shamseddine(Lebanon)
  • Antiangiogenic treatment for the secondline and beyond
    Ozkan Kanat(Turkey)
  • Microbiota and colon cancer
    – Serdar Turhal(Turkey)
11:50 – 12:35

Session XXI: Special Issues in the Management of GI Cancer-1
Chairs:
Halil Kavgaci(Turkey), Ulus Ali Sanlı(Turkey)

11:50-12:05

  • Identifying and management of Identifiying toxidity
    – Guzin Gonullu Demirag(Turkey)

12:05-12:20

  • Identifiying and management of pulmoner toxicity
    Ali Alkan(Turkey)

12:20-12:35

  • Addressing Cardiac toxicity in GI cancer patient
    Tulay Akman(Turkey)
12:35 – 13:15

Session XXII: Special Issues in the Management of GI Cancer-2
Chairs:
Murat Kocer(Turkey), Erkan Dogan(Turkey)

12:35-12:55

  • Management of nausea and vomiting
    Furkan Sarici(Turkey)

12:55- 13:15

  • Management of cancer pain
    Sahin Lacin(Turkey)

13:15 – 13:35

Session XXIII: How to increase international scientific collaboration in the region

Chairs: Ilias Athanasiadis(Greece), Ofer Purim(Israel)

 – Huseyin Abali(Turkey)

13:35 – 14:00

Closing Remarks

Suayib Yalcin(Turkey)

Adjourn